文献速递主动脉疾病

腹主动脉瘤腔内修复术后瘤囊缩小的预后意义

Prognostic Significance of Aneurysm Sac Shrinkage After Endovascular Aneurysm Repair.
PubMed 文献 · J Endovasc Ther · 2020-06-26

该系统评价与荟萃分析纳入8项病例对照研究共17096例患者,比较EVAR术后瘤囊缩小与稳定或增大患者的结局。瘤囊缩小者死亡、二次干预、晚期并发症及破裂风险均显著低于无缩小者,提示应将瘤囊转归纳入随访策略。

要点

  • EVAR术后12个月瘤囊缩小合并发生率为48%(95%CI 40%~56%)。
  • 瘤囊缩小者死亡风险显著更低(HR 0.73,95%CI 0.60~0.87)。
  • 未获瘤囊缩小者应加强随访监测。

核心结论

  • 瘤囊缩小与更好的生存及更低的二次干预和EVAR相关并发症发生率相关。
  • 瘤囊缩小的预后意义应纳入随访策略,未缩小者应加强监测。

研究设计与样本

  • 通过NICE的Healthcare Databases Advanced Search接口检索MEDLINE和EMBASE。
  • 纳入比较EVAR术后瘤囊缩小与稳定或增大患者结局的病例对照研究。
  • 定量合成纳入8项研究,共17096例患者(瘤囊缩小8518例,无缩小8578例)。
  • 二分类结局用OR及95%CI合并,时间事件数据用逆方差法以HR及95%CI合并,采用随机效应模型。

主要发现

  • 12个月瘤囊缩小合并发生率为48%(95%CI 40%~56%)。
  • 瘤囊缩小者死亡风险显著低于稳定或增大者(HR 0.73,95%CI 0.60~0.87)。
  • 瘤囊缩小者二次干预风险显著更低(HR 0.42,95%CI 0.29~0.62)。
  • 瘤囊缩小者晚期并发症风险显著更低(HR 0.37,95%CI 0.24~0.56)。
  • 瘤囊缩小者破裂 odds 显著更低(OR 0.09,95%CI 0.02~0.36)。

临床怎么用

  • 可将EVAR术后瘤囊是否缩小作为风险分层与随访强度调整的参考指标。
  • 对未达到瘤囊缩小的患者应考虑加强影像随访监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To investigate whether patients who develop aneurysm sac shrinkage following endovascular aneurysm repair (EVAR) have better outcomes than patients with a stable or increased aneurysm sac. Materials and Methods: The Healthcare Databases Advanced Search interface developed by the National Institute for Health and Care Excellence was used to interrogate MEDLINE and EMBASE. Thesaurus headings were adapted accordingly. Case-control studies were identified comparing outcomes in patients demonstrating aneurysm sac shrinkage after EVAR with those of patients with a stable or expanded aneurysm sac. Pooled estimates of dichotomous outcome data were calculated using the odds ratio (OR) and 95% confidence interval (CI). Meta-analysis of time-to-event data was conducted using the inverse-variance method; the results are reported as a summary hazard ratio (HR) and 95% CI. Summary outcome estimates were calculated using random-effects models. Results: Eight studies were included in quantitative synthesis reporting a total of 17,096 patients (8518 patients with sac shrinkage and 8578 patients without sac shrinkage). The pooled incidence of sac shrinkage at 12 months was 48% (95% CI 40% to 56%). Patients with aneurysm sac shrinkage had a significantly lower hazard of death (HR 0.73, 95% CI 0.60 to 0.87), secondary interventions (HR 0.42, 95% CI 0.29 to 0.62), and late complications (HR 0.37, 95% CI 0.24 to 0.56) than patients with a stable or increased aneurysm sac. Furthermore, their odds of rupture were significantly lower than those in patients without shrinkage (OR 0.09, 95% CI 0.02 to 0.36). Conclusion: Sac regression is correlated to improved survival and a reduced rate of secondary interventions and EVAR-related complications. The prognostic significance of sac regression should be considered in surveillance strategies. Intensified surveillance should be applied in patients who fail to achieve sac regression following EVAR.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Antoniou GA, Alfahad A, Antoniou SA, et al. Prognostic Significance of Aneurysm Sac Shrinkage After Endovascular Aneurysm Repair. J Endovasc Ther. 2020. PMID: 32589118. doi:10.1177/1526602820937432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。